title: FPIN's Clinical Inquiries. Treatment of motion sickness.
authors.affiliation: University of North Carolina School of Medicine, Chapel Hill, NC, USA. msutton@unch.unc.edu
authors.forename: Matthew
authors.initials: M
authors.lastname: Sutton
authors.forename: Anne L
authors.initials: AL
authors.lastname: Mounsey
authors.forename: Roger G
authors.initials: RG
authors.lastname: Russell
mesh_terms: D000932:Antiemetics / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D020939:Zingiber officinale; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D009041:Motion Sickness / Q000188:drug therapy*; D017294:Ondansetron / Q000627:therapeutic use; D008517:Phytotherapy; D012601:Scopolamine / Q000627:therapeutic use
chemical_list: D000932:Antiemetics; D018680:Cholinergic Antagonists; D006633:Histamine Antagonists; D017294:Ondansetron; D012601:Scopolamine